EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Association of the STAT3 rs1053004 Polymorphism With Hepatocellular Carcinoma in Iraqi Patients With Hepatitis B

Hawraa Ahmed Ali iD, Thuraya Aamer Habeeb iD, Zahraa F Shaker iD, Zahraa Q Jasim iD

International Journal of Hepatology · 2026-01 · 2026 (1)

DOI: 10.1155/ijh/6122232 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Hepatology, online erschienen am 29.07.2026. Verfasst von Hawraa Ahmed Ali und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy Techniques, Babylon Technical Institute, Al-Furat Al-Awsat Technical University, Al-Najaf, Iraq, atu.edu.iq. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

HCC is still one of the main causes of cancer‐related fatalities despite years of intensive attempts to prevent it. One known risk factor is a persistent hepatitis B virus (HBV) infection. Previous studies have indicated a contribution of the STAT3 signaling pathway to carcinogenesis through inflammation mechanisms. In this study, we tried to explore the correlation between STAT3 rs1053004 polymorphism and HCC occurrence in people with HBV infection in Iraq.

Methods

A case–control approach was applied with the inclusion of 80 patients with HCC due to HBV infection, 80 patients with CHB, and 80 healthy controls. The study was based on genotyping of the STAT3 rs1053004 polymorphism by a TaqMan SNP genotyping assay. Multivariate logistic regression analysis was used to assess the genetic association with disease risk, adjusting for potential confounding factors.

Results

The three groups under study had significantly different genotype and allele distributions ( p < 0.001). The HCC group had more T alleles than the other groups. Additionally, patients with the TT genotype had a greater risk of HCC (adjusted odds ratio [AOR] = 4.26; 95 % confidence interval [CI] = 1.89–9.62; p < 0.001), and this impact was observed in patients with cirrhosis, high serum HBV DNA levels, and negative HBeAg status.

Conclusion

STAT3 rs1053004 polymorphism plays a significant role in the development of HCC risk in people with HBV infection.

Schlagwörter

Stichwörter der Autor:innen

IraqSTAT3hepatitis B virushepatocellular carcinomasingle-nucleotide polymorphism

Autor:innen und Institutionen

  • Department of Pharmacy Techniques, Babylon Technical Institute, Al-Furat Al-Awsat Technical University, Al-Najaf, Iraq, atu.edu.iq.
  • Department of Medical Laboratory Techniques, Polytechnic College-Karbala, Al-Furat Al-Awsat Technical University, Al-Najaf, Iraq, atu.edu.iq.
  • College of Dentistry, Mustansiriyah University, Baghdad, Iraq, uomustansiriyah.edu.iq.

ORCID-Profile: Hawraa Ahmed Ali, Thuraya Aamer Habeeb, Zahraa F Shaker, Zahraa Q Jasim

Zitieren

APA

Ali, H. A., Habeeb, T. A., Shaker, Z. F., & Jasim, Z. Q. (2026). Association of the STAT3 rs1053004 Polymorphism With Hepatocellular Carcinoma in Iraqi Patients With Hepatitis B. International Journal of Hepatology, 2026(1). https://doi.org/10.1155/ijh/6122232

Vancouver

Ali HA, Habeeb TA, Shaker ZF, Jasim ZQ. Association of the STAT3 rs1053004 Polymorphism With Hepatocellular Carcinoma in Iraqi Patients With Hepatitis B. International Journal of Hepatology. 2026;2026(1). doi:10.1155/ijh/6122232

BibTeX
@article{Ali2026,
  author = {Ali, Hawraa Ahmed and Habeeb, Thuraya Aamer and Shaker, Zahraa F and Jasim, Zahraa Q},
  title = {Association of the STAT3 rs1053004 Polymorphism With Hepatocellular Carcinoma in Iraqi Patients With Hepatitis B},
  journal = {International Journal of Hepatology},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/ijh/6122232}
}
Kostenlos starten →